Patient Guide: A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 21 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT07071519
Status: 🟢 Enrolling Now
Condition: Ulcerative Colitis
Phase: PHASE3

Where You Can Participate

This study is available at 21 locations across the country.

Top locations include:
  • • Phoenix, Arizona
  • • Atlanta, Georgia
  • • Greenville, South Carolina
  • • And 18 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis - Join Clinical Trial NCTNCT07071519

How to Join This Clinical Trial - NCTNCT07071519

Learn how to participate in this PHASE3 trial studying an investigational therapy for Ulcerative Colitis. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Ulcerative Colitis. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Ulcerative Colitis
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT07071519 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 21 locations. Find a study site near you:

Clinical Research Site

Phoenix, Arizona 85016 - United States

Status: RECRUITING

Clinical Research Site

Atlanta, Georgia 30342 - United States

Status: RECRUITING

Clinical Research Site

Greenville, South Carolina 29615 - United States

Status: RECRUITING

Clinical Research Site

Brussels, Brussels Capital 1200 - Belgium

Status: RECRUITING

Clinical Research Site

Münster, North Rhine-Westphalia 48149 - Germany

Status: RECRUITING

Clinical Research Site

Thessaloniki, 54642 - Greece

Status: RECRUITING

Clinical Research Site

San Giovanni Rotondo, Foggia 71013 - Italy

Status: RECRUITING

Clinical Research Site

Naples, Napoli 80131 - Italy

Status: RECRUITING

Clinical Research Site

Rome, Roma 00168 - Italy

Status: RECRUITING

Clinical Research Site

Trieste, 34137 - Italy

Status: RECRUITING

And 11 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Ulcerative Colitis:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships